![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1629656
Ä¡·á¿ë ÄÜÅÃÆ®·»Áî ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°Therapeutic Contact Lenses Market, By Product Type, By Application, By Distribution Channel, By Geography |
¼¼°è Ä¡·á¿ë ÄÜÅÃÆ®·»Áî ½ÃÀåÀº 2024³â¿¡´Â 49¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. 2024-2031³âÀÇ CAGRÀº 7%¸¦ ³ªÅ¸³»°í, 2031³â¿¡´Â 79¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
º¸°í ¹üÀ§ | º¸°í¼ ¼¼ºÎÁ¤º¸ | ||
---|---|---|---|
±âÁØ¿¬µµ | 2023 | 2024³â ½ÃÀå ±Ô¸ð | 49¾ï 1,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2019-2023³â | ¿¹Ãø ±â°£ | 2024-2031³â |
¿¹Ãø ±â°£(2024-2031³â) CAGR : | 7.00% | 2031³â °¡Ä¡ ¿¹Ãø | 79¾ï ´Þ·¯ |
Ä¡·á¿ë ÄÜÅÃÆ®·»Áî´Â ½Ã·Â ±³Á¤°ú ´« °Ç°À» Áö¿øÇϱâ À§ÇØ ¾È°ú Àü¹®°¡°¡ ó¹æÇϴ Ư¼ö ·»ÁîÀÔ´Ï´Ù. ÀÌ ·»Áî´Â ±¼Àý ÀÌ»ó, ³½Ã, ³ë¾È, ´Ù¾çÇÑ ¾È Ç¥¸é ÁúȯÀ» Ä¡·áÇϱâ À§ÇØ ¼³°èµÇ¾ú½À´Ï´Ù. ¹é³»Àå, ¿øÃß°¢¸·, ´ç´¢º´¼º ¸Á¸·Áõ µîÀÇ ¾ÈÁúȯÀÇ ¹ß»ý·üÀÇ »ó½ÂÀÌ, Ä¡·á¿ë ÄÜÅÃÆ®·»Áî ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¶Ù¾î³ ÄèÀû¼º°ú Àå½Ã°£ÀÇ Âø¿ë ´É·ÂÀ» Á¦°øÇÏ´Â ÄÜÅÃÆ®·»Áî ¼ÒÀçÀÇ ±â¼úÀû Áøº¸°¡ ÀÌ·¯ÇÑ ·»ÁîÀÇ ÀÀ¿ë ¹üÀ§¸¦ ´õ¿í ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÀϺΠÁö¿ª¿¡¼´Â »ç¿ë °¡´ÉÇÑ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÎ½Ä ºÎÁ·°ú Ư¼ö ·»ÁîÀÇ ³ôÀº °¡°ÝÀÌ ½ÃÀå ¼ºÀåÀ» ¾î´À Á¤µµ ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼¼°èÀÇ Ä¡·á¿ë ÄÜÅÃÆ®·»Áî ½ÃÀåÀº ÁÖ·Î Ä¡·á¸¦ ÇÊ¿ä·Î ÇÏ´Â ¾ÈÁúȯ¿¡ °É¸®±â ½¬¿î ³ëÀÎ Àα¸ Áõ°¡¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. WHO¿¡ µû¸£¸é 2024³â 10¿ù Ãß°è¿¡¼´Â 2050³â±îÁö ¼¼°è Àüü¿¡¼ 13¾ï¸í ÀÌ»óÀÌ 65¼¼ ÀÌ»óÀÌ µÈ´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ ´ç´¢º´ ¸Á¸·Áõ°ú °°Àº Áõ»óÀ» ÀÏÀ¸Å°´Â ´ç´¢º´°ú °°Àº »ýȰ ½À°üº´ÀÇ À¯º´·ü »ó½Âµµ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Ç¸®ÄÜ ÇÏÀ̵å·Î°Ö ·»Áî´Â ±âÁ¸ ·»Áî¿¡ ºñÇØ »ê¼Ò Åõ°ú¼ºÀÌ ³ô°í, Âø¿ë ±â°£ÀÇ ¿¬ÀåÀÌ °¡´ÉÇϰí, ȯÀÚÀÇ ÄÄÇöóÀ̾𽺵µ Çâ»óÇϱ⠶§¹®¿¡ ½ÃÀå ä¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ƯÈ÷ Èñ±ÍÁúȯ¿ë Ư¼ö·»ÁîÀÇ ºñ¿ëÀÌ ³ô°í ½ÅÈï°æÁ¦±¹¿¡¼ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÎ½Ä ºÎÁ·ÀÌ Å« °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÄÜÅÃÆ®·»Áî Á¦Á¶¸¦ À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ½ÂÀÎ ¹× ÀÎÇÁ¶ó ¿ä±¸»çÇ×Àº ½Å±Ô Âü°¡Àڵ鿡°Ô ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í ¾ÖÇø®ÄÉÀ̼ÇÀÇ È®´ë¿Í Àú·ÅÇÑ ·»Á °³¹ßÇϱâÀ§ÇÑ ¿¬±¸ °³¹ßÀÌ ÁøÇà ÁßÀ̱⠶§¹®¿¡ ÇâÈÄ ¸î ³â µ¿¾È »õ·Î¿î ºñÁî´Ï½º ±âȸ°¡ ¿¹»óµË´Ï´Ù.
º» º¸°í¼¿¡¼´Â ¼¼°èÀÇ Ä¡·á¿ë ÄÜÅÃÆ®·»Áî ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2023³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¼ºÀå ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
¼¼°è Ä¡·á¿ë ÄÜÅÃÆ®·»Áî ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀº ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î °ÔÀçµË´Ï´Ù.
º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷Àº Johnson & Johnson, Alcon, Bausch Lomb, CooperVision, Menicon Co., Ltd., Hoya Corporation, Carl Zeiss AG, EssilorLuxottica, SynergEyes, Inc., OptiMed Technology, Inc., Aerie Pharmaceuticals, Inc. ing Technologies, Inc., and X-Cel Specialty Contacts. µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°èÀÇ Ä¡·á¿ë ÄÜÅÃÆ®·»Áî ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è Ä¡·á¿ë ÄÜÅÃÆ®·»Áî ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.
The global therapeutic contact lenses market is estimated to be valued at USD 4.91 Bn in 2024 and is expected to reach USD 7.90 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 4.91 Bn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 7.00% | 2031 Value Projection: | US$ 7.90 Bn |
Therapeutic contact lenses are specialized lenses prescribed by eye care professionals to support vision correction and eye health. These lenses are designed to treat refractive errors, astigmatism, presbyopia, and various ocular surface diseases. The rising incidence of ocular disorders such as cataract, keratoconus, and diabetic retinopathy has been driving the demand for therapeutic contact lenses. Additionally, technological advancements in contact lens materials that offer superior comfort and extended wear capabilities are further widening the application scope of these lenses. However, lack of awareness about available treatment options and high cost of specialized lenses in some regions may restrain the market growth to some extent.
The global therapeutic contact lenses market is primarily driven by the growing geriatric population which is more susceptible to ocular diseases requiring treatment. According to the WHO, in October 2024, estimates reveal over 1.3 billion people globally will be aged 65 years or older by 2050. Additionally, rising prevalence of lifestyle diseases such as diabetes propelling conditions like diabetic retinopathy is also fueling the demand. The market is also witnessing increasing adoption of silicone hydrogel lenses owing to their enhanced oxygen permeability compared to conventional lenses, allowing extended wear periods and better patient compliance. However, high cost of specialty lenses particularly for rare conditions and lack of awareness about treatment options in developing economies are major challenges. Moreover, stringent regulatory approvals and infrastructure requirements for contact lenses manufacturing pose difficulties for new entrants. Nevertheless, ongoing R&D to expand applications and develop affordable lenses presents new opportunities in the coming years.
This report provides in-depth analysis of the global therapeutic contact lenses market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global therapeutic contact lenses market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson, Alcon, Bausch + Lomb, CooperVision, Menicon Co., Ltd., Hoya Corporation, Carl Zeiss AG, EssilorLuxottica, SynergEyes, Inc., OptiMed Technology, Inc., Aerie Pharmaceuticals, Inc., Eyevance Pharmaceuticals, Ocular Therapeutix, Inc., Visioneering Technologies, Inc., and X-Cel Specialty Contacts
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global therapeutic contact lenses market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global therapeutic contact lenses market